544 related articles for article (PubMed ID: 17604450)
21. Characterization of chikungunya virus infection of a human keratinocyte cell line: role of mosquito salivary gland protein in suppressing the host immune response.
Puiprom O; Morales Vargas RE; Potiwat R; Chaichana P; Ikuta K; Ramasoota P; Okabayashi T
Infect Genet Evol; 2013 Jul; 17():210-5. PubMed ID: 23583544
[TBL] [Abstract][Full Text] [Related]
22. Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis.
Phuklia W; Kasisith J; Modhiran N; Rodpai E; Thannagith M; Thongsakulprasert T; Smith DR; Ubol S
Virus Res; 2013 Nov; 177(2):179-88. PubMed ID: 24012515
[TBL] [Abstract][Full Text] [Related]
23. Reemergence of endemic Chikungunya, Malaysia.
AbuBakar S; Sam IC; Wong PF; MatRahim N; Hooi PS; Roslan N
Emerg Infect Dis; 2007 Jan; 13(1):147-9. PubMed ID: 17370532
[TBL] [Abstract][Full Text] [Related]
24. Update: chikungunya fever diagnosed among international travelers--United States, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):276-7. PubMed ID: 17392679
[TBL] [Abstract][Full Text] [Related]
25. Chikungunya virus isolates with/without A226V mutation show different sensitivity to IFN-a, but similar replication kinetics in non human primate cells.
Bordi L; Meschi S; Selleri M; Lalle E; Castilletti C; Carletti F; Chiappini R; Di Caro A; Capobianchi MR
New Microbiol; 2011 Jan; 34(1):87-91. PubMed ID: 21344151
[TBL] [Abstract][Full Text] [Related]
26. Chikungunya and the nervous system: what we do and do not know.
Arpino C; Curatolo P; Rezza G
Rev Med Virol; 2009 May; 19(3):121-9. PubMed ID: 19274635
[TBL] [Abstract][Full Text] [Related]
27. Genomic evolution and phenotypic distinctions of Chikungunya viruses causing the Indian Ocean outbreak.
Powers AM
Exp Biol Med (Maywood); 2011 Aug; 236(8):909-14. PubMed ID: 21750019
[TBL] [Abstract][Full Text] [Related]
28. Origin, evolution, and phylogeography of recent epidemic CHIKV strains.
Lo Presti A; Ciccozzi M; Cella E; Lai A; Simonetti FR; Galli M; Zehender G; Rezza G
Infect Genet Evol; 2012 Mar; 12(2):392-8. PubMed ID: 22244786
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases.
Larrieu S; Pouderoux N; Pistone T; Filleul L; Receveur MC; Sissoko D; Ezzedine K; Malvy D
J Clin Virol; 2010 Jan; 47(1):85-8. PubMed ID: 20004145
[TBL] [Abstract][Full Text] [Related]
30. Biology and pathogenesis of chikungunya virus.
Schwartz O; Albert ML
Nat Rev Microbiol; 2010 Jul; 8(7):491-500. PubMed ID: 20551973
[TBL] [Abstract][Full Text] [Related]
31. The Chikungunya threat: an ecological and evolutionary perspective.
Chevillon C; Briant L; Renaud F; Devaux C
Trends Microbiol; 2008 Feb; 16(2):80-8. PubMed ID: 18191569
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test.
Litzba N; Schuffenecker I; Zeller H; Drosten C; Emmerich P; Charrel R; Kreher P; Niedrig M
J Virol Methods; 2008 Apr; 149(1):175-9. PubMed ID: 18294706
[TBL] [Abstract][Full Text] [Related]
33. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
35. Chikungunya virus infection.
Sam IC; AbuBakar S
Med J Malaysia; 2006 Jun; 61(2):264-9. PubMed ID: 16898330
[TBL] [Abstract][Full Text] [Related]
36. Genetic characterization of E2 region of Chikungunya virus circulating in Odisha, Eastern India from 2010 to 2011.
Sahu A; Das B; Das M; Patra A; Biswal S; Kar SK; Hazra RK
Infect Genet Evol; 2013 Aug; 18():113-24. PubMed ID: 23684629
[TBL] [Abstract][Full Text] [Related]
37. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response.
Her Z; Malleret B; Chan M; Ong EK; Wong SC; Kwek DJ; Tolou H; Lin RT; Tambyah PA; Rénia L; Ng LF
J Immunol; 2010 May; 184(10):5903-13. PubMed ID: 20404274
[TBL] [Abstract][Full Text] [Related]
38. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases.
Simon F; Savini H; Parola P
Med Clin North Am; 2008 Nov; 92(6):1323-43, ix. PubMed ID: 19061754
[TBL] [Abstract][Full Text] [Related]
39. Clinical and molecular characterization of chikungunya virus in South Thailand.
Theamboonlers A; Rianthavorn P; Praianantathavorn K; Wuttirattanakowit N; Poovorawan Y
Jpn J Infect Dis; 2009 Jul; 62(4):303-5. PubMed ID: 19628911
[TBL] [Abstract][Full Text] [Related]
40. Human muscle satellite cells as targets of Chikungunya virus infection.
Ozden S; Huerre M; Riviere JP; Coffey LL; Afonso PV; Mouly V; de Monredon J; Roger JC; El Amrani M; Yvin JL; Jaffar MC; Frenkiel MP; Sourisseau M; Schwartz O; Butler-Browne G; Desprès P; Gessain A; Ceccaldi PE
PLoS One; 2007 Jun; 2(6):e527. PubMed ID: 17565380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
